Transparent Ceramics Market Witness Growth Based On Increasing Demand From Numerous Application Industries Till 2024:Grand View Research,inc.
The global transfection reagent & equipment market is
expected to reach USD 1,086.02 million by 2022, according to a new report by
Grand View Research, Inc. This anticipated growth in demand can be attributed
to growing need for protein production, biopharmaceutical development, and
vaccine research and development; all of which rely heavily on cytological
R&D and transfection.
Larger market entities are also
involved in efforts to expand their market presence in the Asia Pacific region
and tap the high potential for growth available. Expected growth of genomic and
proteomic research is also a strong factor which will positively impact the
growth in demand for transfection.
Browse full research report on Transfection Reagent And
Equipment Market: http://www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market
Further key findings from
the study suggest:
- Out of both the broad segments of products available,
transfection equipment accounted for a larger share of the market in 2014
and owing to their inherently more expensive nature than reagents are
expected to maintain this dominant position over the forecast period.
- The market space for transfection has an abundant
number of methods to achieve the aforementioned. However, these vary
significantly in usage rates and implementation complexities.
Electroporation and liposomal transfection combine to account for over 30%
of the market owing to high associated advantages.
- Growing applications of transfection techniques poise
the segments in a strong position and estimated valuation clocks usage of
transfection in gene expression at over USD 130 million and for protein
production at over USD 110 million for the year 2014.
- North America was observed to be responsible for the
largest share of revenue in 2014 which amounted to a little over USD 240
million. The United States houses the headquarters of operations for a
number of market leaders and a number of established research and
development. This provides a strong platform for development, manufacture
& distribution various vaccines, and biopharmaceuticals which fuels
market growth.
- However, it is Asia Pacific region which is
anticipated to witness significant growth over the forecast period in
various segments owing to considerable growth of cytological research,
development of biosimilar drugs and high potential of growth in these
relatively untapped regional segments.
- Asia Pacific is expected to grow at a significant
rate over the forecast period in terms of increasing production and
development of vaccines, drugs, and new biologics. Supportive government
initiatives pertaining to increasing investments by manufacturers and
governments in biopharmaceutical manufacturing and high untapped market
opportunities are the important factors accounting for the expected growth
of market in this region over the forecast period.
- Promega, Roche and Thermo Fisher owned Life Technologies
accounted for the largest of revenue in 2014 and are involved in new
product development for expansion of their portfolios over the forecast
period. Acquisition of smaller players is also expected over the forecast
period by larger companies
- Key market players in the Transfection Reagent &
Equipment Market include BTX (Harvards Apparatus Inc.), SignaGen
Laboratories, OriGene Technologies, EMD Millipore, VWR International LLC,
Bio-Rad Laboratories Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza
AG, Life Technologies (Thermo Fisher), and Promega Corporation.
Browse more reports of this category by Grand View
Research : http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented Transfection Reagent &
Equipment Market on the basis of product, method, application, and region:
Global Transfection reagents & equipment Product Outlook
(Revenue, USD Million, 2012 - 2022)
- Reagents
- Equipment
Global Transfection reagents & equipment Method
Outlook (Revenue, USD Million, 2012 - 2022)
- Electroporation
- Liposomes
- Particle
Bombardment
- Microinjection
- Adenoviral
vectors
- Direct
microinjection
- Calcium
phosphate
- DEAE-dextran
- Magnetic
beads
- Activated
Dendrimers
- Laserfection
Global Transfection reagents & equipment Application
Outlook (Revenue, USD Million, 2012 - 2022)
- Gene
expression studies
- Protein
production
- Transgenic
delivery
- Cancer
research
- Biomedical
research
Transfection reagents & equipment Regional Outlook
(Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment